GODAVARI

Godavari Drugs Share Price

₹113.30 -2.95 (-2.54%)

29 Dec, 2024 08:52

SIP TrendupStart SIP in GODAVARI

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -1.05%
  • Over 3 Month -8.37%
  • Over 6 Month + 11.77%
  • Over 1 Year + 24.16%
SIP Lightning

Smart Investing Starts Here Start SIP with Godavari Drugs for Steady Growth!

Invest Now

Godavari Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Godavari Drugs Financials

Godavari Drugs Technicals

EMA & SMA

Current Price
₹113.30
-2.95 (-2.54%)
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹118.24
  • 50 Day
  • ₹119.84
  • 100 Day
  • ₹118.35
  • 200 Day
  • ₹112.86

Resistance and Support

114.58 Pivot Speed
  • R3 119.97
  • R2 118.38
  • R1 116.17
  • S1 112.37
  • S2 110.78
  • S3 108.57

What's your outlook on Godavari Drugs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Godavari Biorefineries Ltd has an operating revenue of Rs. 2,769.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -16% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 2% is fair but needs improvement. The company has a debt to equity of 71%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -15% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 23 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 83 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Godavari Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-30 Quarterly Results
2024-02-13 Quarterly Results (Revised)
2023-11-14 Quarterly Results

Godavari Drugs F&O

Godavari Drugs Shareholding Pattern

No data available.

About Godavari Drugs

  • NSE Symbol
  • GODAVARI
  • BSE Symbol
  • 530317
  • Chairman & Managing Director
  • Mr. Samir Shantilal Somaiya
  • ISIN
  • INE362C01012

Similar Stocks to Godavari Drugs

Godavari Drugs FAQs

Godavari Drugs share price is ₹113 As on 29 December, 2024 | 08:38

The Market Cap of Godavari Drugs is ₹85.3 Cr As on 29 December, 2024 | 08:38

The P/E ratio of Godavari Drugs is 12.9 As on 29 December, 2024 | 08:38

The PB ratio of Godavari Drugs is 2.2 As on 29 December, 2024 | 08:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23